Neurofilament accumulation disrupts autophagy in giant axonal neuropathy.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 40059823.
- Also identified by DOI 10.1172/jci.insight.177999 and PMC identifier 11949051.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Neurofilament accumulation is associated with many neurodegenerative diseases, but it is the primary pathology in giant axonal neuropathy (GAN). This childhood-onset autosomal recessive disease is caused by loss-of-function mutations in gigaxonin, the E3 adaptor protein that enables neurofilament degradation. Using a combination of genetic and RNA interference approaches, we found that dorsal root ganglia from mice lacking gigaxonin have impaired autophagy and lysosomal degradation through 2 mechanisms. First, neurofilament accumulations interfere with the distribution of autophagic organelles, impairing their maturation and fusion with lysosomes. Second, the accumulations attract the chaperone 14-3-3, which is responsible for the proper localization of the key autophagy regulator transcription factor EB (TFEB). We propose that this dual disruption of autophagy contributes to the pathogenesis of other neurodegenerative diseases involving neurofilament accumulations.
Medical subject headings
- Autophagy
- Giant Axonal Neuropathy
- Cytoskeletal Proteins
- Neurofilament Proteins
- Intermediate Filaments